vivaxim solution
sanofi pasteur limited - salmonella typhi vi capsular polysaccharide vaccine; hepatitis a vaccine, inactivated - solution - 25mcg; 160unit - salmonella typhi vi capsular polysaccharide vaccine 25mcg; hepatitis a vaccine, inactivated 160unit - vaccines
rivaxa 20 mg filmtabletten
rivaxa 15 mg und 20 mg filmtabletten starterpackung
rivaxa 2,5 mg filmtabletten
rivaxa 10 mg filmtabletten
rivaxa 15 mg filmtabletten
scabivax contagious pustular dermatitis (orf) vacc
schering plough limited - contagious pustular dermatitis vaccine - suspension for skin scarification - ovine - immunological - live vaccine
scabivax contagious pustular dermatitis (orf) vaccine
intervet ireland limited - contagious pustular dermatitis vaccine - suspension for skin scarification - per cent - orf virus vaccine / contagious pustular dermatitis vaccine - ovine - immunological - live vaccine
scabivax contagious pustular dermatitis (orf) vaccine suspension for skin scarification
intervet ireland limited - contagious pustular dermatitis - cutaneous suspension - . - orf virus / contagious pustular dermatitis - sheep - immunological - live vaccine
rivaxotor 10 rivaroxaban 10 mg tablet blister pack
arrotex pharmaceuticals pty ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium lauryl sulfate; croscarmellose sodium; magnesium stearate; hypromellose; titanium dioxide; iron oxide red; macrogol 3350 - ? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks),? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe